The Role of the Independent Sector, Post-COVID with Jim Easton (CEO of Care UK)

Pharma Market Access Insights - from Mtech Access

We are joined by Jim Easton (CEO of Care UK) to discuss the role of the independent sector in supporting the NHS and the wider care industry, both during the pandemic and in a post-COVID world.
In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) is joined by NHS and other UK healthcare experts who offer real-world, first-hand insight into the challenges facing the NHS and explore the implications for market access, brand and HCP-facing teams, in pharmaceutical and medical device companies.
In this episode, Tom asks Jim:
- How has the private sector responded to COVID?
- What have been the biggest challenges/risks in private provision?
- What has been the impact of COVID on public-private relationships and collaboration?
- How important is the private sector going forward, and in which service/therapy areas?
- What does the future hold for independent providers?
This episode was originally broadcast on 19th June 2020 as a webinar. This podcast series has been converted from our webinar series 'How is COVID-19 impacting the NHS?'.
Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

챕터

1. The Role of the Independent Sector, Post-COVID with Jim Easton (CEO of Care UK) (00:00:00)

2. How has the independent sector responded to COVID? (00:03:20)

3. What challenges and risks have the independent sector faced? (00:09:35)

4. Change in the NHS vs the independent sector (00:15:22)

5. What role will the independent sector play in the future? (00:23:06)

6. What does the future hold for independent providers? (00:33:05)